Instadose Pharma Corp delivers 2,125 metric tons of medicinal cannabis from South Africa at North Macedonia in a historic international delivery, this record-breaking shipment represents the world’s largest cannabis shipment to date.
CHESAPEAKE, Va., January 5, 2022 /CNW/ – (OTC PINK:INSD) Instadose Pharma Corp (the “Company” or “Instadose”) Establishes the largest continuous supply of medicinal cannabis in the world. Instadose Pharma Corp is extremely proud to announce the delivery of a record shipment of high quality medicinal cannabis flowers. The delivery of 2,125 Metric Tons was completed on December 25, 2021, from Johannesburg, South Africa at Skopje, North Macedonia. With this successful delivery, Instadose Pharma Corp becomes a global leader in the international supply of high quality outdoor grown medicinal cannabis and agricultural pharmaceutical ingredients. The product has been sold and is intended for licensed pharmaceutical customers in the European Union.
“This is a historic delivery and represents only the beginning of Instadose Pharma’s potential. This delivery validates our business model and Instadose Pharma Corp as a global leader in this industry. This has always been my vision and I am very excited about what this delivery means and what is on the horizon.”
Grant F. Sanders, Founder and President
Instadose specializes in premium quality medicinal cannabis flower that contains high levels of THC (delta-9-tetrahydrocannabinol) which is unique to Instadose Pharma. High levels of THC are in continued demand from pharmaceutical customers and Instadose Pharma will continue to grow and provide quality products to meet market demand.
About INSTADOSE PHARMA CORP
Instadose Pharma Corp is establishing a large outdoor cultivation, cultivation, production and global distribution business platform for medicinal cannabis and cannabinoid oil (the “Global distribution platform“). Instadose Canada strives to use the global distribution platform to open the commercial gateway to a new wholesale market capable of providing companies in the pharmaceutical industry with large, sustainable, consistent, diverse and affordable supplies. low cost medical cannabis and high quality cannabinoid oil for bulk use as an active pharmaceutical ingredient.
Instadose Pharma Corp’s global distribution platform spans five (5) global continents to date, including Africa, Europe, Asia, South America, and North America. On each continent, Instadose Pharma Corp establishes operating subsidiaries and joint venture partnerships to secure access to government-issued licenses and permits in countries such as The Democratic Republic of Congo, the Republic of North Macedonia, the Portuguese Republic, the Republic of India, Colombia, Mexico, and Canada, each seeking to increase their level of participation within the global medicinal cannabis industry.
Instadose Pharma’s relationships with international partners are based on long-term, sustainable agreements that were originally designed to give back to people and protect the natural environment. Instadose Pharma projects aim to improve the quality of life, provide jobs, fresh water, education, food security and capital.
This press release contains forward-looking statements and information (collectively “forward-looking information”) within the meaning of applicable securities laws relating to the Company’s plans and other aspects of our anticipated future opportunities. Forward-looking information generally uses words such as “anticipate”, “believe”, “continue”, “trend”, “support”, “project”, “expect”, “plan”, “budget”, “target “, “direction”, “plan”, “objective”, “strategy”, “target”, “intention”, “estimate”, “potential”, or similar words suggesting future results, statements that actions, events or conditions “may”, “would”, “could” or “will” be made or occur in the future, including statements about our plans, direction, goals, priorities and position. In particular, and without limiting the generality of the foregoing, this press release contains forward-looking information regarding our upcoming medical cannabis shipments. Forward-looking information is based on certain key expectations and assumptions made by our Board of Directors and our management. Although we believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on forward-looking information as the Company cannot guarantee that it will prove to be accurate. Because forward-looking information deals with future events and conditions, it, by its very nature, involves inherent risks and uncertainties. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking information and, therefore, no assurance can be given that any of the events anticipated by the forward-looking information will occur or will occur, or if any of them does, what benefits will we get. Management has included the above summary of the assumptions and risks associated with the forward-looking information provided in this press release in order to provide securityholders with a more complete perspective on our future operations and such information may not be appropriate to other purposes. Readers are cautioned that the foregoing lists of factors are not exhaustive. These forward-looking statements are made as of the date of this press release and we disclaim any intention or obligation to publicly update any forward-looking information, whether as a result of new information, future events or results or otherwise, other as required by applicable securities laws.
Show original content to download multimedia:https://www.prnewswire.com/news-releases/instadose-pharma-corp-ships-2-125-metric-tons—largest-international-cannabis-delivery-in-history-301454538.html
SOURCE Instadose Pharma Corporation
Show original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2022/05/c1195.html